Next Article in Journal
Valorization of Phosphorus Secondary Raw Materials by Acidithiobacillus ferrooxidans
Previous Article in Journal
New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria
Article

Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line

by 1,†, 1,†, 1,†, 2, 3, 1, 1 and 1,*
1
Department of Chemistry, Shantou University Medical College, Shantou 515041, Guangdong, China
2
Department of Pharmacology, Shantou University Medical College, Shantou 515041, Guangdong, China
3
Department of Hepatobiliary Surgery II, Zhujiang Hospital of Southern Medical University, Guangzhou 510280, Guangdong, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Maria Emília de Sousa
Received: 28 February 2017 / Revised: 9 March 2017 / Accepted: 9 March 2017 / Published: 16 March 2017
Cancer is a major public health concern worldwide. Adverse effects of cancer treatments still compromise patients’ quality of life. To identify new potential anticancer agents, a series of novel pyrazoline derivatives were synthesized and evaluated for cytotoxic effects on HepG-2 (human liver hepatocellular carcinoma cell line) and primary hepatocytes. Compound structures were confirmed by 1H-NMR, mass spectrometry, and infrared imaging. An in vitro assay demonstrated that several compounds exerted cytotoxicity in the micromolar range. Benzo[b]thiophen-2-yl-[5-(4-hydroxy-3,5-dimethoxy-phenyl)-3-(2-hydroxy-phenyl)-4,5-dihydo-pyrazol-1-yl]-methanone (b17) was the most effective anticancer agent against HepG-2 cells owing to its notable inhibitory effect on HepG-2 with an IC50 value of 3.57 µM when compared with cisplatin (IC50 = 8.45 µM) and low cytotoxicity against primary hepatocytes. Cell cycle analysis and apoptosis/necrosis evaluation using this compound revealed that b17 notably arrested HepG-2 cells in the G2/M phase and induced HepG-2 cells apoptosis. Our findings indicate that compound b17 may be a promising anticancer drug candidate. View Full-Text
Keywords: pyrazoline; anticancer activity; HepG-2 cells; apoptosis pyrazoline; anticancer activity; HepG-2 cells; apoptosis
Show Figures

Figure 1

MDPI and ACS Style

Xu, W.; Pan, Y.; Wang, H.; Li, H.; Peng, Q.; Wei, D.; Chen, C.; Zheng, J. Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line. Molecules 2017, 22, 467. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules22030467

AMA Style

Xu W, Pan Y, Wang H, Li H, Peng Q, Wei D, Chen C, Zheng J. Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line. Molecules. 2017; 22(3):467. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules22030467

Chicago/Turabian Style

Xu, Weijie, Ying Pan, Hong Wang, Haiyan Li, Qing Peng, Duncan Wei, Cheng Chen, and Jinhong Zheng. 2017. "Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line" Molecules 22, no. 3: 467. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules22030467

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop